Skip to main content
. Author manuscript; available in PMC: 2024 Apr 5.
Published in final edited form as: Phys Med Biol. 2023 Apr 5;68(8):10.1088/1361-6560/acc37c. doi: 10.1088/1361-6560/acc37c

Table 2.

Comparison of optimized plans (Opt) for validation to corresponding clinical (Clin) plans, predicted (Pred) doses to clinical plans, automated (Auto) plans to predicted doses, and automated plans to clinical plans, along with optimization times for optimized and automated plans.

Mean Absolute Differences Mean Differences DSC Mean (Range)
Dwell Times Overall Dosea Dwell Times Overall Dose 100% Isodose Optimization Time
s (%b) cGy (%) s cGy (%) s
Optimized Plan Results for Validation (Clin-Opt)

T&O 4.1 (0.9%) 6.9 (1.1%) 0.3 1.8 (0.3%) 0.99 75 (63-96)
T&O + N 5.6 (1.0%) 8.9 (1.3%) 0.2 1.7 (0.3%) 0.98 124 (80-227)
T&R 2.7 (0.7%) 6.1 (0.8%) 0.2 1.3 (0.2%) 0.98 90 (69-126)
T&R + N 4.0 (0.7%) 7.6 (1.0%) 0.2 2.0 (0.3%) 0.99 113 (94-130)
Automated Plan Results (All T&O)

Clin-Pred NA 57.6 (9.1%) NA 9.4 (1.7%) 0.90 NA
Pred-Auto NA 38.8 (6.1%) NA −15.5 (−2.5%) 0.96 81 (70-92)
Clin-Auto 10.3 (2.1%) 40.9 (6.5%) 0.0 −6.2 (−0.8%) 0.91 81 (70-92)

T&O = tandem-and-ovoid, T&R = tandem-and-ring, N = needle(s), DSC = Dice similarity coefficient.

a

Over all voxels for each patient, where % is relative to prescription

b

Relative to the total plan dwell time (corresponding values for mean differences were less than 0.1% so are not shown)